Cart
sales@molnova.com
HIV-1 inhibitor-6?
CAS No. 1821309-39-0
HIV-1 inhibitor-6?( 3-Pyridinecarboxamide, 1,4-dihydro-1-methyl-N-(5-nitro-1,2-benzisothiazol-3-yl)-4-oxo- )
Catalog No. M28936 CAS No. 1821309-39-0
3-Pyridinecarboxamide, 1,4-dihydro-1-methyl-N-(5-nitro-1,2-benzisothiazol-3-yl)-4-oxo- is a potent HIV-1 pre-mRNA selective splicing inhibitor that blocks HIV replication.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 259 | Get Quote |
|
| 10MG | 447 | Get Quote |
|
| 25MG | 714 | Get Quote |
|
| 50MG | 1017 | Get Quote |
|
| 100MG | 1368 | Get Quote |
|
| 500MG | 2673 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameHIV-1 inhibitor-6?
-
NoteResearch use only, not for human use.
-
Brief Description3-Pyridinecarboxamide, 1,4-dihydro-1-methyl-N-(5-nitro-1,2-benzisothiazol-3-yl)-4-oxo- is a potent HIV-1 pre-mRNA selective splicing inhibitor that blocks HIV replication.
-
Description3-Pyridinecarboxamide, 1,4-dihydro-1-methyl-N-(5-nitro-1,2-benzisothiazol-3-yl)-4-oxo- is a potent HIV-1 pre-mRNA selective splicing inhibitor that blocks HIV replication.
-
In Vitro——
-
In Vivo——
-
Synonyms3-Pyridinecarboxamide, 1,4-dihydro-1-methyl-N-(5-nitro-1,2-benzisothiazol-3-yl)-4-oxo-
-
PathwayMicrobiology/Virology
-
TargetHIV
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1821309-39-0
-
Formula Weight330.32
-
Molecular FormulaC14H10N4O4S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 3.33 mg/mL (10.08 mM)
-
SMILESO=C(C1=CN(C)C=CC1=O)NC2=NSC3=C2C=C([N+]([O-])=O)C=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Wang GR, et al. New flavonoids with 2BS cell proliferation promoting effect from the seeds of Trigonella foenum-graecum L. J Nat Med. 2010 Jul;64(3):358-61.
molnova catalog
related products
-
Zalcitabine
A pyrimidine analog reverse transcriptase inhibitor (NRTI) for the treatment of HIV/AIDS.
-
HMN214
HMN-214(IVX214) is a potent PLK1 inhibitor with an average IC50 of 0.12 μM.
-
BNM-III-170
BNM-III-170 is a small-molecule CD4-mimetic compound that enhances vaccine efficacy against HIV-1 challenge in vivo.
